Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
about
The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo.C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemia
P2860
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
@ast
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
@en
type
label
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
@ast
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
@en
prefLabel
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
@ast
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
@en
P2093
P2860
P50
P356
P1476
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia
@en
P2093
David F Claxton
David J Feith
Matthew R MacDougall
Myles C Cabot
P Darrell Neufer
Samy A F Morad
Terence E Ryan
Thomas P Loughran
Todd E Fox
Tonya N Zeczycki
P2860
P304
P356
10.1194/JLR.M067389
P577
2016-05-02T00:00:00Z